203 related articles for article (PubMed ID: 12524223)
1. Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
Iglarz M; Touyz RM; Amiri F; Lavoie MF; Diep QN; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):45-51. PubMed ID: 12524223
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
3. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
Diep QN; El Mabrouk M; Cohn JS; Endemann D; Amiri F; Virdis A; Neves MF; Schiffrin EL
Circulation; 2002 May; 105(19):2296-302. PubMed ID: 12010913
[TBL] [Abstract][Full Text] [Related]
4. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
Schiffrin EL; Larivière R; Li JS; Sventek P
J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
[TBL] [Abstract][Full Text] [Related]
6. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1.
Berthon N; Laurant P; Hayoz D; Fellmann D; Brunner HR; Berthelot A
Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
Johnson RJ; Fink GD; Watts SW; Galligan JJ
J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin.
Intengan HD; Park JB; Schiffrin EL
Hypertension; 1999 Oct; 34(4 Pt 2):907-13. PubMed ID: 10523383
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.
Viel EC; Benkirane K; Javeshghani D; Touyz RM; Schiffrin EL
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H281-8. PubMed ID: 18487445
[TBL] [Abstract][Full Text] [Related]
10. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
Intengan HD; He G; Schiffrin EL
Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
[TBL] [Abstract][Full Text] [Related]
11. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
David FL; Carvalho MH; Cobra AL; Nigro D; Fortes ZB; Rebouças NA; Tostes RC
Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
[TBL] [Abstract][Full Text] [Related]
12. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
13. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
14. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
Molero MM; Giulumian AD; Reddy VB; Ludwig LM; Pollock JS; Pollock DM; Rusch NJ; Fuchs LC
J Hypertens; 2002 Sep; 20(9):1799-805. PubMed ID: 12195122
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
16. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
Pu Q; Touyz RM; Schiffrin EL
J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
[TBL] [Abstract][Full Text] [Related]
17. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430
[TBL] [Abstract][Full Text] [Related]
18. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
[TBL] [Abstract][Full Text] [Related]
20. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice.
Ko EA; Amiri F; Pandey NR; Javeshghani D; Leibovitz E; Touyz RM; Schiffrin EL
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1789-95. PubMed ID: 17142347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
